| Symbol | AVTR |
|---|---|
| Name | AVANTOR, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | RADNOR CORPORATE CENTER, BUILDING ONE,SUITE 200,100 MATSONFORD ROAD, RADNOR, Pennsylvania, 19087, United States |
| Telephone | +1 610 386-1700 |
| Fax | — |
| — | |
| Website | https://www.avantorsciences.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The companys offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas. Additional info from NASDAQ: |
Eck Steven W 🟢 acquired 31.6K shares of Avantor, Inc. (AVTR) Transaction Date: Apr 03, 2026 | Filing ID: 023934
Read moreAvantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Read moreNew Form ARS - Avantor, Inc. <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001308179-26-000162 <b>Size:</b> 59 MB
Read moreNew Form DEFA14A - Avantor, Inc. <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001628280-26-021573 <b>Size:</b> 3 MB
Read moreNew Form DEF 14A - Avantor, Inc. <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001628280-26-021572 <b>Size:</b> 94 MB
Read moreNew Form SCHEDULE 13G/A - Avantor, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000784 <b>Size:</b> 7 KB
Read moreDirector MEHRA SANJEEV K 🟢 acquired 125.0K shares of Avantor, Inc. (AVTR) at $8.01 ($1.0M) Transaction Date: Mar 10, 2026 | Filing ID: 016904
Read more